Frontlight ResearchEarly access
Trial site
Florida Cancer Specialists
- 5running trials
- 2closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Metastatic breast cancer2 trials
- Bladder cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Ovarian cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 23 trials
- Phase 33 trials
- Phase 1/21 trial
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Recruiting2 trials
- Lead sponsor
- Pfizer2 trials
- AbbVie1 trial
- Astellas Pharma Global Development, Inc.1 trial
- Daiichi Sankyo1 trial
- Seagen, a wholly owned subsidiary of Pfizer1 trial
- and 1 more
Running trials
Recruiting
Active, not recruiting
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer1 recruiting
- Lung cancer1 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026